1 Amin E M, Oltean S, Hua J, et al. WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing[J]. Cancer Cell, 2011, 20(6): 768~780.2 An P, Yin Y, Fan A, et al. The effects of the WT1 gene on apoptosis and development-related gene expression in porcine kidney fibroblasts and swine testis cells[J]. Mol Reprod Dev, 2013, 80(5): 414~425.3 Beckwith J B. Nephrogenic rests and the pathogenesis of Wilms tumor: Developmental and clinical considerations[J]. Am J Med Genet, 1998, 79(4): 268~273.4 Biason-Lauber A. Control of sex development[J]. Best Pract Res Clin Endocrinol Metab, 2010, 24(2): 163~186.5 Bruening W, Pelletier J. A non-AUG translational initiation event generates novel WT1 isoforms[J]. Biol Chem, 1996, 271(15): 8646~8654.6 Call K M, Glaser T, Ito C Y, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus[J]. Cell, 1990, 60(3): 509~520.7 Costantini F. Renal branching morphogenesis: Concepts, questions, and recent advances[J]. Differentiation, 2006, 74(7): 402~421.8 Davies J A, Ladomery M, Hohenstein P, et al. Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the WT1 tumour suppressor is required for nephron differentiation[J]. Hum Mol Genet, 2004, 13(2): 235~246.9 Davies R C, Calvio C, Bratt E, et al. WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes[J]. Genes Dev, 1998, 12(20): 3217~3225.10 Dudnakova T, Spraggon L, Slight J, et al. Actin: A novel interaction partner of WT1 influencing its cell dynamic properties[J]. Oncogene, 2010, 29(7): 1085~1092.11 Gao F, Zhang J, Wang X, et al. Wt1 functions in ovarian follicle development by regulating granulosa cell differentiation[J]. Hum Mol Genet, 2014, 23(2): 333~341.12 Guo J K, Menke A L, Gubler M C, et al. WT1 is a key regulator of podocyte function: Reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis[J]. Hum Mol Genet, 2002, 11(6): 651~659.13 Haber D A, Sohn R L, Buckler A J, et al. Alternative splicing and genomic structure of the Wilms tumor gene WT1[J]. Proc Natl Acad Sci USA, 1991, 88(21): 9618~9622.14 Hastie N D. The genetics of Wilms’ tumor——A case of disrupted development[J]. Annu Rev Genet, 1994, 28: 523~558.15 Herzer U, Crocoll A, Barton D, et al. The Wilms tumor suppressor gene WT1 is required for development of the spleen[J]. Curr Biol, 1999, 9(15): 837~840.16 Kent J, Coriat A M, Sharpe P T, et al. The evolution of WT1 sequence and expression pattern in the vertebrates[J]. Oncogene, 1995, 11(9): 1781~1792.17 Klamt B, Koziell A, Poulat F, et al. Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms[J]. Hum Mol Genet, 1998, 7(4): 709~714.18 Kousta E, Papathanasiou A, Skordis N. Sex determination and disorders of sex development according to the revised nomenclature and classification in 46, XX individuals[J]. Hormones(Athens), 2010, 9(3): 218~231.19 Kreidberg J A, Sariola H, Loring J M, et al. WT1 is required for early kidney development[J]. Cell, 1993, 74(4): 679~691.20 Li X, Oghi K A, Zhang J, et al. Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organ ogenesis[J]. Nature, 2003, 426(6964): 247~254.21 Lin L, Achermann J C. Steroidogenic factor-1(SF-1, Ad4BP, NR5A1) and disorders of testis development[J]. Sex Dev, 2008, 2(4~5): 200~209.22 Moore A W, McInnes L, Kreidberg J, et al. YAC complementation shows a requirement for WT1 in the development of epicardium, adrenal gland and throughout nephrogenesis[J]. Development, 1999, 126(9): 1845~1857.23 Morrison A A, Viney R L, Ladomery M R. The post-transcriptional roles of WT1, a multifunctional zinc-finger protein[J]. Biochim Biophys Acta, 2008, 1785(1): 55~62.24 Mundlos S, Pelletier J, Darveau A, et al. Nuclear localization of the protein encoded by the Wilms’ tumor gene WT1 in embryonic and adult tissues[J]. Development, 1993, 119(4): 1329~1341.25 Palmer R E, Kotsianti A, Cadman B, et al. WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin[J]. Curr Biol, 2001, 11(22): 1805~1809.26 Parker K L, Rice D A, Lala D S, et al. Steroidogenic factor 1: An essential mediator of endocrine development[J]. Recent Prog Horm Res, 2002, 57: 19~36.27 Pavenstadt H. Roles of the podocyte in glomerular function[J]. Am J Physiol Renal Physiol, 2000, 278(2): F173~F179.28 Pelletier J, Bruening W, Kashtan C E, et al. Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome[J]. Cell, 1991, 67(2): 437~447.29 Roberts S G. Transcriptional regulation by WT1 in development[J]. Curr Opin Genet Dev, 2005, 15(5): 542~547.30 Scharnhorst V, Dekker P, van der Eb A J, et al. Internal translation initiation generates novel WT1 protein isoforms with distinct biological properties[J]. Biol Chem, 1999, 274(33): 23456~23462.31 Scholz H, Kirschner K M. A role for the Wilms’ tumor protein WT1 in organ development[J]. Physiology(Bethesda), 2005, 20: 54~59.32 Shen W H, Moore C C, Ikeda Y, et al. Nuclear receptor steroidogenic factor 1 regulates the mullerian inhibiting substance gene: A link to the sex determination cascade[J]. Cell, 1994, 77(5): 651~661.33 Steege A, Fahling M, Paliege A, et al. Wilms’ tumor protein(-KTS) modulates renin gene transcription[J]. Kidney Int, 2008, 74(4): 458~466.34 Takayama K, Sasano H, Fukaya T, et al. Immunohistochemical localization of Ad4-binding protein with correlation to steroidogenic enzyme expression in cycling human ovaries and sex cord stromal tumors[J]. Clin Endocrinol Metab, 1995, 80(9): 2815~2821.35 Vainio S, Lin Y. Coordinating early kidney development: Lessons from gene targeting[J]. Nat Rev Genet, 2002, 3(7): 533~543.36 Wagner K D, Wagner N, Vidal V P, et al. The Wilms’ tumor gene WT1 is required for normal development of the retina[J]. EMBO J, 2002, 21(6): 1398~1405.37 Wagner N, Wagner K D, Xing Y, et al. The major podocyte protein nephrin is transcriptionally activated by the Wilms’tumor suppressor WT1[J]. Am Soc Nephrol, 2004, 15(12): 3044~3051.38 Wang X N, Li Z S, Ren Y, et al. The Wilms tumor gene, WT1, is critical for mouse spermatogenesis via regulation of sertoli cell polarity and is associated with non-obstructive azoospermia in humans[J]. PLoS Genet, 2013, 9(8): e1003645.39 Xu P X, Zheng W, Huang L, et al. Six1 is required for the early organogenesis of mammalian kidney[J]. Development, 2003, 130(14): 3085~3094. |